SunTrust Upgrades Pfizer To Neutral On Allergan Deal
November 25, 2015 at 09:45 AM EST
When Pfizer ( PFE ) and Allergan ( AGN ) agreed to merge both stocks initially fell , although analysts began to warm to the deal and the benefits Allergan will bring Pfizer . Today, SunTrust Robinson Humphrey’s John Boris joined that group, upgraded Pfizer from Reduce to Neutral, and increasing his target price by $3 to $37. Read More »
